Vaccine effectiveness of COVID-19 and rebound in the real world

被引:3
作者
Park, Myung-Bae [1 ]
Sim, Boram [2 ]
机构
[1] Pai Chai Univ, Dept Hlth & Welf, Daejeon, South Korea
[2] Hlth Insurance Review & Assessment Serv HIRA, HIRA Res Inst, Wonju, South Korea
关键词
COVID-19; SARS-CoV-2; Vaccines; Rebound; Mortality; HOSPITALIZATIONS; DEATHS;
D O I
10.1007/s10238-023-01204-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We intend to evaluate the relationship between the rates of global SARS-CoV-2 vaccination and the number of COVID-19 confirmed cases, as well as the mortality rate after the declaration of a pandemic. Of the data from 191 countries at the time of data retraction, we selected 111 countries that have SARS-CoV-2 vaccination reports. We stratified countries into high-income and non-high-income countries (HIC and non-HIC) based on World Bank income-group. We used a fixed-effects model (FEM) and performed a longitudinal analysis. The number of confirmed cases decreased as the vaccination rates increased in both non-HICs (B = - 0.027, T = - 2.0) and HICs (B = - 0.207, T = - 17.5). The number of deaths decreased as the vaccination rates increased in both non-HICs (B = - 0.151, T = - 2.3) and HICs (B = - 0.230, T = - 40.9). For full vaccination, this measure had a negative association with daily confirmed cases and daily deaths in both non-HICs and HICs. In non-HICs, daily cases and daily deaths decreased as the first vaccination and full vaccination coverages increased. However in HICs, daily cases and daily deaths decreased as the first vaccination and full vaccination coverages increased in the early phase, but after a certain period, they tended to increase again. We observed a significant association between the increase in vaccination coverage in the real world and reduced daily confirmed cases and deaths. However, as the confirmed cases and deaths have rebounded in HICs, our findings indicate that COVID-19 is not completely prevented through vaccine distribution.
引用
收藏
页码:4975 / 4983
页数:9
相关论文
共 43 条
[1]  
Andrews N, 2021, medRxiv
[2]  
Aran D., 2021, ESTIMATING REAL WORL, DOI DOI 10.1101/2021.02.05.21251139
[3]   Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study [J].
Bernal, Jamie Lopez ;
Andrews, Nick ;
Gower, Charlotte ;
Robertson, Chris ;
Stowe, Julia ;
Tessier, Elise ;
Simmons, Ruth ;
Cottrell, Simon ;
Roberts, Richard ;
O'Doherty, Mark ;
Brown, Kevin ;
Cameron, Claire ;
Stockton, Diane ;
McMenamin, Jim ;
Ramsay, Mary .
BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
[4]   Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020 [J].
Bo, Yacong ;
Guo, Cui ;
Lin, Changqing ;
Zeng, Yiqian ;
Li, Hao Bi ;
Zhang, Yumiao ;
Hossain, Md Shakhaoat ;
Chan, Jimmy W. M. ;
Yeung, David W. ;
Kwok, Kin On ;
Wong, Samuel Y. S. ;
Lau, Alexis K. H. ;
Lao, Xiang Qian .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 102 :247-253
[5]  
Centers for Disease Control and Prevention, 2023, STAY DAT COVID 19 VA
[6]  
Centers for Disease Control and Prevention, 2023, COVID 19 TREATM MED
[7]   Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19 [J].
Cook, T. M. ;
Roberts, J., V .
ANAESTHESIA, 2021, 76 (05) :608-616
[8]  
Department of Health and Social Care, 2021, The Department of Health and Social Cares Written Evidence to the NHS Pay Review Body (NHSPRB) for the 2021/22 Pay Round
[9]   Disparities in COVID-19 Vaccination among Low-, Middle-, and High-Income Countries: The Mediating Role of Vaccination Policy [J].
Duan, Yuqi ;
Shi, Junyi ;
Wang, Zongbin ;
Zhou, Shuduo ;
Jin, Yinzi ;
Zheng, Zhi-Jie .
VACCINES, 2021, 9 (08)
[10]   The find of COVID-19 vaccine: Challenges and opportunities [J].
ElBagoury, Marwan ;
Tolba, Mahmoud M. ;
Nasser, Hebatallah A. ;
Jabbar, Abdul ;
Elagouz, Ahmed M. ;
Aktham, Yahia ;
Hutchinson, Amy .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (03) :389-416